| Literature DB >> 33076730 |
Florian Sagmeister1,2, Sebastian Herrmann3, Tobias Gassenmaier2, Peter Bernhardt4, Volker Rasche5, Andreas Liebold6, Frank Weidemann3,7, Horst Brunner1, Meinrad Beer1,2.
Abstract
OBJECTIVE: To assess the influence of pressure recovery (PR)-corrected haemodynamic parameters on outcome in patients with aortic stenosis.Entities:
Keywords: Aortic valve stenosis; cardiac MR; echocardiography; outcome prediction; pressure recovery; reclassification
Mesh:
Year: 2020 PMID: 33076730 PMCID: PMC7592334 DOI: 10.1177/0300060520954708
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Schematic drawing of the course of the blood stream during left ventricular (LV) systolic ejection from the LV outflow tract to the tubular ascending aorta.
Figure 2.Representative transthoracic echocardiography (TTE) image (parasternal long axis view, end-diastolic) showing the ascending aorta and diameter measurement at the level of the sinotubular junction (STJ).
Figure 3.(a) Schematic drawing and (b) representative steady-state free precession (SSFP)-cine cardiac magnetic resonance image (3 chamber view) of the ascending aorta showing diameter measurement positions: 1, aortic annulus; 2, Sinus of Valsalva (SoV); 3, sinutubular junction (STJ); and 4, proximal tubular ascending aorta.
Demographic, clinical and medication data for patients with severe degenerative aortic stenosis.
| Demographic parameter | |
| Patients included | 25 |
| Age (years) | 68 ± 10 |
| Male: female | 18: 7 |
| BSA (kg/m2) | 1.91 ± 0.22 |
| Height (cm) | 170 ± 10 |
| Weight (kg) | 80 ± 15 |
| Medication | |
| Diuretics | 17/25 (68%) |
| Statins | 13/25 (52%) |
| ACE-inhibitors/AT IIra | 12/25 (48%) |
| Beta blocker | 12/25 (48%) |
| Calcium antagonists | 6/25 (24%) |
| Clinical parameter | |
| Hypertension | 20/25 (80%) |
| Hyperlipidaemia | 12/25 (48%) |
| Coronary artery disease | 9/25 (36%) |
| Diabetes | 7/25 (28%) |
| Renal insufficiency | 2/25 (8%) |
| Smoker | 6/25 (24%) |
| NYHA I | 0/25 (0%) |
| NYHA II | 7/25 (28%) |
| NYHA III | 15/25 (60%) |
| NYHA IV | 2/25 (8%) |
Data presented as mean ± SD or n (%) prevalence.
BSA, body surface area; ACE, angiotensin-converting-enzyme; AT IIra, angiotensin II receptor antagonists; NYHA, New York Heart Association classification.
Haemodynamic analysis by transthoracic echocardiography (TTE) in patients with severe degenerative aortic stenosis.
| Parameter | Parameter | ||
|---|---|---|---|
| Vmax | 4.34 ± 0.83 | Vmean | 3.30 ± 0.76 |
| pmax | 78 ± 29 | pmean | 51 ± 22 |
| PRTTE | 15 ± 4 | iPRTTE | 0.21 ± 0.07 |
| VTILVOT | 23 ± 6 | VTIAK | 102 ± 25 |
| EOA (cm2) | 0.85 ± 0.24 | EOAi (cm2/m2) | 0.46 ± 0.16 |
| ELCO (cm2) | 0.99 ± 0.34 | ELI (cm2/m2) | 0.53 ± 0.22 |
| dTTE_LVOT (cm) | 2.3 ± 0.1 | ATTE_LVOT (cm2) | 4.0 ± 0.4 |
| dTTE_STJ (cm) | 3.0 ± 0.33 | ATTE_STJ (cm2) | 7.33 ± 1.57 |
Data presented as mean ± SD.
Vmax, maximal velocity across the aortic valve; pmax, maximal pressure gradient across the aortic valve; PR, pressure recovery; VTI, velocity time integral; LVOT, left ventricular outflow tract; EOA, effective orifice area; ELCO, energy loss coefficient; d, diameter; STJ, sinotubular junction; Vmean, mean velocity across the aortic valve; Pmean, mean pressure gradient across the aortic valve; iPR, index pressure recovery; AK, aortic valve; EOAi, indexed aortic orifice area; ELI, energy loss index; A, area.
Pressure recovery (PR), iPR and energy loss index using aortic areas in three-chamber view using cardiac magnetic resonance imaging (CMR).
| Parameter | ||||
|---|---|---|---|---|
| Anatomic site | PR (mmHg) | iPR (%) | ELCO (cm2) | ELI (cm2/m2) |
| Beginning of systole | ||||
| SoV | 15 ± 5.6 | 21 ± 7.4 | 1.1 ± 0.36 | 0.59 ± 0.23 |
| STJ | 20 ± 7.8 | 27 ± 9.2 | 1.2 ± 0.41 | 0.64 ± 0.26 |
| Ascending aorta | 18 ± 6.3 | 24 ± 7.8 | 1.1 ± 0.37 | 0.61 ± 0.23 |
| End of systole | ||||
| SoV | 14 ± 7.5 | 20 ± 7.0 | 1.10 ± 0.35 | 0.59 ± 0.23 |
| STJ | 19 ± 7.2 | 26 ± 9.2 | 1.17 ± 0.40 | 0.63 ± 0.26 |
| Ascending aorta | 17 ± 6.9 | 23 ± 8.8 | 1.14 ± 0.37 | 0.61 ± 0.23 |
SoV, Sinus of Valsava; STJ, sinotubular junction; iPR, index pressure recovery; ELCO, energy loss coefficient; ELI, energy loss index.
Figure 4.Scatter plots showing correlation between cardiac magnetic resonance imaging (MRI) and transthoracic echocardiography (TTE) results for (a) pressure recovery (PR), r = 0.73 (P <0.001); and (b) index pressure recovery (iPR), r = 0.69 (P <0.001), measured at the sinutubular junction.
Figure 5.Frequency of clinically relevant pressure recovery (dark grey) and aortic stenosis severity reclassification (light grey) depending on imaging modality (transthoracic echocardiography [TTE] versus steady-state free precession [SSFP]-cardiac magnetic resonance imaging [CMR] in 3-chamber view [3CV]) and measurement location for CMR (sinus, Sinus of Valsalva; stj, sinutubular junction; or pAoA, proximal tubular ascending aorta); TTE measurements were obtained at the end of diastole, and SSFP measurements at the beginning of systole. Plx, parasternal long axis.
Figure 6.Changes of aortic stenosis severity from transthoracic echocardiography (TTE) measurements and cardiac magnetic resonance imaging (MR) in 3-chamber view (3CV) measurements without consideration versus with consideration of pressure recovery (PR). EOAi, effective orifice area index; PLX, parasternal long axis; ED, end of diastole; ELI, energy loss index; STJ, sinutubular junction; BS, beginning of systole.
Cox regression analysis for predicting all-cause mortality in patients with severe degenerative aortic stenosis.
| Univariable | ||||
|---|---|---|---|---|
| Characteristic | HR | 95% CI | Statistical significance | Wald |
| Age | 1.186 | 1.018, 1.381 | 4.774 | |
| Sex | 1.178 | 0.237, 5.846 | 0.040 | |
| EOAi | 60.638 | 0.953, 3 858 | 3.753 | |
| ELI | 16.443 | 0.9775, 277 | 3.772 | |
HR, hazard ratio; CI, confidence interval; EOAi, effective orifice area index; ELI, energy loss index.
Cox regression analysis for 9-month NYHA ≥2 and 10-year NYHA ≥2 in patients with severe degenerative aortic stenosis.
| Univariable | Univariable | |||||
|---|---|---|---|---|---|---|
| 9-month NYHA ≥2 | 10-year NYHA ≥2 | |||||
| Characteristic | HR | 95% CI | Wald | HR | 95% CI | Wald |
| Age | 1.068 | 0.988, 1.154 | 2.743 | 1.048 | 0.976, 1.125 | 1.646 |
| Sex | 2.180 | 0.483, 9.835 | 1.027 | 1.766 | 0.475, 6.575 | 0.720 |
| EOAi | 1.476 | 0.048, 45.495 | 0.050 | 0.291 | 0.003, 26.400 | 0.288 |
| ELI | 1.414 | 0.126, 15.923 | 0.079 | 0.287 | 0.011, 7.659 | 0.555 |
NYHA, New York Heart Association classification; HR, hazard ratio; CI, confidence interval; EOAi, effective orifice area index; ELI, energy loss index.
There were no statistically significant correlations (all P > 0.05).